Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

Merck (MRK) announced the opening of a new, $1B, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham, North Carolina, ...

No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited ... She’ll now continue to share her experiences through EMD Serono’s ongoing “I’m Ready” campaign.

The Merck KGaA collaborated with actress and patient advocate Selma Blair for the I’m Ready campaign. When EMD Serono embarked on a campaign to empower patients living with relapsing multiple ...

Dr Reddy's, Merck Serono in pact to develop biotech drugs Germany's Merck KGaA, have entered into a partnership to co-develop a portfolio of biosimilar compounds (biotechnology drugs) in the ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...

Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the “real culprit” for Merck shares remaining under ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma’s under-the-skin version of its blockbuster cancer drug Keytruda.

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

"This collaboration highlights EMD Serono's commitment to digital-first patient engagement, ensuring that individuals living with HIV have access to proactive and personalized health support ...